MNKD

#2084
Mannkind Corporation
3.2800
+8.43%
Sector:
Base:
Profit Currency:
Daily Range
3.2800
3.2800
Year Range
3.0200
6.5100
Daily Change
+8.43%
Monthly Change
-41.22%
6 month change
-38.11%
Year Change
-38.11%
Previous Close
3.0250
Open
3.2800
Bid
Ask
Low
3.2800
High
3.2800
Volume
153
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.0063 B
  • Employee 407
  • Founded N/A
  • CEO Michael Castagna
  • Website www.mannkindcorp.com
  • Headquarter Delaware, United States
  • FIGI BBG000PPL3G9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
64.3
Price to sales ratio
6.39
Dividends per share
—
Dividend yield %
—

MannKind Corporation

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

News